13157-89-6

Upstream product

• 13157-90-9 2-[3,4-bis(phenylmethoxy)phenyl]-3,5,7-tris(phenylmethoxy)chromen-4-one 
• 117-39-5 quercetol 

Downstream Products

• 289472-00-0 C₇₆⁽¹³⁾CH₇₀O₁₃ 
• 55313-03-6 1-(2',4',6'-trihydroxyphenyl)-2-hydroxyethanone 
• 1254040-41-9 C₃₇H₂₉NO₆ 
• 1254040-42-0 C₃₇H₂₉F₃O₆ 
• 1254040-43-1 C₃₇H₃₂O₇ 
• 1466397-28-3 C₂₉H₂₂O₆ 
• 1466397-24-9 C₁₉H₁₅NO₁₀ 
• 1466397-25-0 C₂₀H₁₇NO₁₀ 
• 1466397-26-1 C₂₂H₂₀N₂O₁₁ 
• 1466397-27-2 C₂₃H₂₂N₂O₁₁ 
• 1466397-29-4 C₃₇H₃₅NO₁₀ 
• 1466397-30-7 C₃₈H₃₇NO₁₀ 
• 1580490-08-9 C₃₁H₃₇BrO₉ 
• 1642558-71-1 C₂₁H₁₅NO₆ 

Relevant academic research and scientific papers

Isotopic labelling of Quercetin 4'-O-β-D-glucoside

[2-13C]-Quercetin-4'-O-β-glucoside was synthesised in four steps and 28% yield from barium [13C]-carbonate. This short route will be applicable to the synthesis of radiolabelled quercetin-4'-O-β-D-glucoside from barium [14

Idnhibition of antibacterial resistance by 3',4'-difluoroquercetin and its derivative

The present invention relates to 3andprime;,4andprime;-difluoroquercetin having antibacterial activity on multiple drug resistant bacteria and a novel derivative thereof. A quercetin derivative compound of the present invention exhibits a significant antibacterial activity on Gram-positive multiple drug resistant bacteria, exhibits strong antibacterial activity only on Gram-negative multiple drug resistant bacteria, and a significant synergistic effect occurs when an antibiotic which does not have antibacterial activity or has low antibacterial activity and the compound of the present invention are mixed and treated in Gram-negative multiple drug resistant bacteria, thereby being able to exhibit an excellent antibacterial effect on Gram-positive multiple drug resistant bacteria, Gram-negative multiple drug resistant bacteria, and antibiotic-resistant bacteria thereof.COPYRIGHT KIPO 2020